home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

118.10 -1.53 (-1.28%)

Official Closing Price Updated: 7:00 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

1 Healthcare Stock to Consider Right Now and 2 to Brush Off

May 09, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks ↗

May 08, 2025

Pharma ETFs closely watched as Trump's drug policies stir market volatility. Funds offer sector exposure but differ in risk levels and growth potential.

Via Benzinga

Topics ETFs Government

2 Beaten-Down Stocks That Are Great Buys on the Dip ↗

May 08, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

Merck & Co Unusual Options Activity ↗

May 05, 2025

Via Benzinga

Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto

May 08, 2025

From Merck & Co., Inc.

Via Business Wire

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought ↗

May 07, 2025

Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.

Via Benzinga

Merck to Participate in the Bank of America 2025 Global Healthcare Conference

May 07, 2025

From Merck & Co., Inc.

Via Business Wire

What's going on in today's session: S&P500 movers ↗

May 06, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 06, 2025

Via Benzinga

Why the dividend investor may take a look at MERCK & CO. INC. (NYSE:MRK). ↗

May 06, 2025

Uncovering Dividend Opportunities with MERCK & CO. INC. (NYSE:MRK).

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

May 05, 2025

Via Benzinga

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

May 03, 2025

Via The Motley Fool

Topics Economy Government Stocks

8 Health Care Stocks Whale Activity In Today's Session ↗

May 01, 2025

Via Benzinga

Merck & Co. Inc. (NYSE:MRK): A Potential Undervalued Opportunity ↗

April 30, 2025

Merck & Co. Inc. (NYSE:MRK): A Potential Undervalued Opportunity

Via Chartmill

Should Investors Buy Merck Stock After These Huge Risks? ↗

April 30, 2025

Via The Motley Fool

Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now ↗

April 30, 2025

Via The Motley Fool

Topics Government World Trade

How To Put $100 In Your Retirement Fund Each Month With Merck Stock ↗

April 29, 2025

Via Benzinga

Topics Retirement

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

April 29, 2025

From Merck & Co., Inc.

Via Business Wire

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

9 Health Care Stocks Whale Activity In Today's Session ↗

April 28, 2025

Via Benzinga

Why Is Summit Therapeutics Stock Trading Higher On Monday? ↗

April 28, 2025

Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 trial.

Via Benzinga

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion ↗

April 28, 2025

Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.

Via Benzinga

Despite its impressive fundamentals,MERCK & CO. INC. (NYSE:MRK) remains undervalued. ↗

April 28, 2025

Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.

Via Chartmill

Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 28, 2025

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

Topics Government World Trade

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

April 27, 2025

From Merck & Co., Inc.

Via Business Wire

2 Outstanding Dividend Stocks to Buy and Hold For 20 Years ↗

April 26, 2025

Via The Motley Fool

Topics Government World Trade

These S&P500 stocks are moving in today's session ↗

April 25, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Merck Stays Confident On M&A Despite Market Uncertainty: Analyst ↗

April 25, 2025

Merck projects $200 million in tariff costs, boosts U.S. manufacturing plans, and continues M&A efforts amid external pressures and shifting market dynamics.

Via Benzinga

Topics World Trade

What's Going On With Summit Therapeutics Stock On Friday? ↗

April 25, 2025

Summit Therapeutics' partner Akeso received FDA approval for penpulimab-kcqx in NPC, while ivonescimab showed strong data in lung cancer trials.

Via Benzinga

Market Monitor April 25 ( Texas Instruments, Nvidia & Amazon UP, IBM, PepsiCo & Comcast DOWN) ↗

April 25, 2025

Wall Street Rallies Again: Tech Leads the Charge, Alphabet Shines After-Hours

Via Chartmill

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com